Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy
Completed
Conditions studied: Vitrectomy
In brief
This study will evaluate the degree of post-operative ocular inflammation in patients who are undergoing a pars plana vitrectomy.
Key facts
- Study ID
- NCT01319318
- Run by
- Allergan
- People needed
- 25
- Starts
- 2011-03-01
- Expected to finish
- 2012-06-01
- Last updated by the study team
- 2013-07-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Require pars plana vitrectomy in at least 1 eye
- Best corrected visual acuity in the study eye between 20/400 and 20/40
You may not qualify if…
- Use of any NSAIDs (topical or systemic) within 14 days
- Use of topical or systemic steroids within 30 days
- Active eye infection in either eye
- Any eye surgery within 6 months
- Prior pars plana vitrectomy, YAG capsulotomy or uveitis
Where it is running
- Study site — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.